Annette E. Fleckenstein

Annette E. Fleckenstein, MS, PhD

Languages spoken: English

Education History

Undergraduate Western Michigan University
 BS
Graduate Training Western Michigan University
 MS
Doctoral Training Michigan State University
 PhD
Postdoctoral Fellowship National Institutes of Health, National Institute on Drug Abuse - Addiction Research Center
 Postdoctoral Fellow
Postdoctoral Fellowship University of Utah
 Postdoctoral Fellow

Selected Publications

Journal Article

  1. Curtin K, Fleckenstein AE, Keeshin BR, Yurgelun-Todd DA, Renshaw PF, Smith KR, Hanson G (2018). Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder. Neuropsychopharmacology, 43(13), 2548-2555.
  2. German CL, Gudheti MV, Fleckenstein AE, Jorgensen E (2017). Brain Slice Staining and Preparation for Three-Dimensional Super-Resolution Microscopy. Methods in molecular biology (Clifton, N.J.), 1663, 153-162.
  3. Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson G (2015). Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug and alcohol dependence, 146, 30-8.
  4. Baladi MG, Newman AH, Nielsen SM, Hanson GR, Fleckenstein A (2014). Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia. European journal of pharmacology, 732, 105-10.
  5. German CL, Hoonakker AH, Fleckenstein AE, Hanson G (2014). Mephedrone alters basal ganglia and limbic neurotensin systems. Journal of neurochemistry, 130(3), 402-7.
  6. Vieira-Brock PL, McFadden LM, Nielsen SM, Ellis JD, Walters ET, Stout KA, McIntosh JM, Wilkins DG, Hanson GR, Fleckenstein A (2015). Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. The Journal of pharmacology and experimental therapeutics, 355(3), 463-72.
  7. German CL, Fleckenstein AE, Hanson G (2014). Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life sciences, 97(1), 2-8.
  8. McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein A (2015). Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology, 93, 146-54.
  9. German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein A (2015). Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacological reviews, 67(4), 1005-24.
  10. German CL, Alburges ME, Hoonakker AJ, Fleckenstein AE, Hanson G (2014). Mephedrone alters basal ganglia and limbic dynorphin systems. Synapse (New York, N.Y.), 68(12), 634-640.
  11. Fricks-Gleason AN, German CL, Hoonakker AJ, Friend DM, Ganesh KK, Carver AS, Hanson GR, Fleckenstein AE, Keefe K (2016). An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse (New York, N.Y.), 70(4), 139-46.
  12. Pittenger ST, Swalve N, Chou S, Smith MD, Hoonakker AJ, Pudiak CM, Fleckenstein AE, Hanson GR, Bevins R (2016). Sex differences in neurotensin and substance P following nicotine self-administration in rats. Synapse (New York, N.Y.), 70(8), 336-46.
  13. Baladi MG, Nielsen SM, Umpierre A, Hanson GR, Fleckenstein A (2014). Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats. Behavioural pharmacology, 25(8), 758-65.
  14. Baladi MG, Nielsen SM, McIntosh JM, Hanson GR, Fleckenstein A (2016). Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behavioural pharmacology, 27(5), 422-30.
  15. McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein A (2014). Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor. The international journal of neuropsychopharmacology, 17(8), 1315-20.
  16. Vieira-Brock PL, McFadden LM, Nielsen SM, Smith MD, Hanson GR, Fleckenstein A (2015). Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. The international journal of neuropsychopharmacology, 18(12),

Book

  1. Hanson GR, Venturelli PJ, Fleckenstein A (2008). Drugs and Society.
  2. Hanson GR, Venturelli PJ, Fleckenstein A (2002). Drugs and Society.
  3. Hanson GR, Venturelli PJ, Fleckenstein A (2004). Drugs and Society.
  4. Hanson GR, Venturelli PJ, Fleckenstein AE, contributing autho (2000). Drugs and Society.
  5. Hanson GR, Venturelli PJ, Fleckenstein A (2012). Drugs and Society.
  6. Hanson GR, Venturelli PJ, Fleckenstein A (2015). Drugs and Society.
  7. Hanson GR, Venturelli PJ, Fleckenstein A (2018). Drugs and Society.
  8. Hanson GR, Venturelli PJ, Fleckenstein A Drugs and Society.